Britannica Sources used in this answer

How is human insulin produced using genetically engineered Escherichia coli bacteria?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Vaccine development — genetic engineering The generation of vaccines relies heavily on techniques in genetic engineering.

Human insulin is produced using recombinant DNA technology to transform Escherichia coli bacteria into biological factories for protein synthesis.12

The process relies on the known amino acid sequence and chemical structure of human insulin. Because this sequence is established, scientists can reproduce the corresponding DNA in a laboratory setting. This synthesized DNA, which contains the specific instructions for insulin production, is then inserted into a laboratory strain of E. coli.23

Once the modified bacteria incorporate these genes, they are directed to synthesize the human protein. This breakthrough, first commercialized as Humulin in 1982, allowed for the large-scale manufacturing of synthetic human insulin, providing a reliable alternative to previously used animal-derived products. This application of genetic engineering represents a vital milestone in medical science, enabling the efficient production of biologic drugs to treat conditions like diabetes.23